Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
FTO-IN-4
Cat. No.:
OB0425LY-127
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
FTO-IN-4 is a member of the FTO inhibitor family and plays a role in suppressing obesity and metabolic diseases.
Synonyms:
2763577-74-6; FTOIN4
CAS No.:
2763577-74-6
Compound CID:
163198518
Formula:
C22H16Cl2N6O6
Formula Weight:
531.31
Specification
Target:
Fat mass and obesity-associated protein (FTO)
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
FTO-IN-4 can be used for obesity research and corresponding therapeutic drug development.
